In our study, when patients with a diagnosis of diabetes were evaluated, it was noted that the majority of them were using metformin, as monotherapy or in combination with sitagliptin, or insulin, and we assume that the lower levels of IL-18 and hsCRP might be related to this treatment. The gene discussed is IL18; the disease is diabetes mellitus.